This conclusion is further supported by reduction of efficacy of Flavopiridol and CAN 508 in vitro with MCL-1 upregulation/overexpression in at least 2 esophageal adenocarcinoma cells. Here, MCL1 is linked to esophageal adenocarcinoma.